Roy Hardiman
Direktor/Vorstandsmitglied bei The Woodlands Store, Inc.
Vermögen: 2 Mio $ am 31.05.2024
Profil
Roy C.
Hardiman is currently the Director & Co-Owner at The Woodlands Store, Inc. He is also a Trustee at the University of California Santa Barbara Foundation and a Co-Owner at The Woodlands, Inc. Additionally, he holds the position of Chief Business & Legal Officer at Alumis, Inc. since 2021.
In his former positions, Mr. Hardiman served as an Independent Director at Pharmacyclics LLC from 2010 to 2012.
He was the Vice President-Corporate Law & Assistant Secretary at Genentech, Inc. from 1990 to 2009.
From 2015 to 2020, he held the role of Secretary & Chief Business Officer at Principia Biopharma, Inc. He also worked as an Attorney at Morrison & Foerster LLP from 1987 to 1990.
Mr. Hardiman completed his undergraduate and graduate studies at the University of California, Santa Barbara.
He also obtained a graduate degree from UCLA School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. 0,32% | 01.07.2024 | 181 818 ( 0,32% ) | 2 Mio $ | 31.05.2024 |
Aktive Positionen von Roy Hardiman
| Unternehmen | Position | Beginn |
|---|---|---|
| The Woodlands, Inc. | Portfolio Manager-Fixed Income | - |
University of California Santa Barbara Foundation
 University of California Santa Barbara Foundation Investment Trusts/Mutual FundsMiscellaneous University of California Santa Barbara Foundation engages in the provision of management and investment services inside the campus. The company was founded in 1973 and is headquartered in Santa Barbara, CA. | Direktor/Vorstandsmitglied | - |
| The Woodlands Store, Inc. | Direktor/Vorstandsmitglied | 01.01.2009 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | General Counsel | 01.09.2021 |
Ehemalige bekannte Positionen von Roy Hardiman
| Unternehmen | Position | Ende |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | - |
| PHARMACYCLICS, INC. | Direktor/Vorstandsmitglied | 09.11.2012 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 01.01.2009 |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 02.01.1990 |
Ausbildung von Roy Hardiman
| University of California, Santa Barbara | Graduate Degree |
| UCLA School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
| The Woodlands, Inc. | |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Commercial Services |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
University of California Santa Barbara Foundation
University of California Santa Barbara Foundation Investment Trusts/Mutual FundsMiscellaneous University of California Santa Barbara Foundation engages in the provision of management and investment services inside the campus. The company was founded in 1973 and is headquartered in Santa Barbara, CA. | Miscellaneous |
| The Woodlands Store, Inc. |
